Abstract
Three amidinoarylhydrazines 1, three arylazoamidines 2, and nine arylazoamidoximes 3 have been synthesized and investigated for their potential to function as nitric oxide (NO) modulators. In-vitro studies demonstrated that 2 and 3 inhibited platelet aggregation (2c, IC(50 )= 3 microM) which could also be shown in vivo by inhibition of thrombus formation in arterioles (3a, 22%). Moreover, for all compounds antihypertensive effects were examined in vivo with SHR rats, with 2a being the most potent candidate by lowering blood pressure by 19%. However, no common underlying mechanism of action could be shown. Some of these compounds released HNO non-enzymatically. Incubations with NO synthase isoforms (NOSs) revealed, that compounds 1 to 3 were weak substrates for NOSs but arylazoamidoximes 3 remarkably elevated the NOSs activity in the presence of L-arginine (3h, up to fivefold). In addition, we examined effects on arginase and dimethylarginine dimethylaminohydrolase (DDAH), two further enzymes involved in the complex regulation of NO biosynthesis, to elucidate whether the observed in-vivo effects can be traced back to their modulation. Furthermore, the metabolic fate of arylazoamidoximes 3 was addressed by investigation of a poss...Continue Reading
References
May 1, 1991·Archiv der Pharmazie·K RehseE Unsöld
Jan 1, 1980·British Journal of Clinical Pharmacology·P A van Zwieten
Jan 1, 1994·Methods in Enzymology·J M Hevel, M A Marletta
Feb 1, 1996·Archiv der Pharmazie·K RehseD Piechocki
Feb 25, 1998·Archiv der Pharmazie·K RehseB Clement
Sep 15, 1999·Cellular and Molecular Life Sciences : CMLS·J L BoucherJ P Tenu
Nov 9, 2000·Analytical Biochemistry·M Knipp, M Vasák
Sep 7, 2002·Drug Metabolism Reviews·Bernd Clement
Dec 4, 2002·Nature Reviews. Drug Discovery·Patrick Vallance, James Leiper
Jul 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Katrina M MirandaDavid A Wink
Jun 9, 1962·Nature·G V BORN
Feb 24, 2004·Biological Chemistry·Lisa A RidnourDavid A Wink
Mar 1, 2005·Archiv der Pharmazie·Katrin BethgeKlaus Rehse
May 4, 2005·Pharmacology & Therapeutics·Noboru TodaTomio Okamura
Apr 4, 2006·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·P FerroniG Davì
Sep 9, 2006·Biochemical and Biophysical Research Communications·Bernd ClementSabine Heberling
Dec 16, 2006·The Journal of Clinical Hypertension·Leopoldo Raij
Dec 18, 2007·Bioorganic & Medicinal Chemistry·Jürke KotthausBernd Clement
Oct 7, 2008·Trends in Pharmacological Sciences·Jennifer C IrvineBarbara K Kemp-Harper
Nov 18, 2008·Bioorganic & Medicinal Chemistry·Jürke KotthausBernd Clement